BRKR vs CTKB
Bruker Corporation - Common Stock · Cytek Biosciences, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | BRKR | CTKB |
|---|---|---|
| Price | $53.43 | $4.61 |
| Market Cap | $8.14B | $599.22M |
| P/E | — | — |
| P/B | 3.39 | 1.86 |
| P/S | 2.37 | 2.97 |
| ROE | -0.4% | -20.7% |
| Net Margin | -0.3% | -33.0% |
| Gross Margin | 45.9% | 51.8% |
| Revenue Growth | 2.1% | 0.5% |
| Dividend Yield | 0.37% | — |
| EPS | -$0.06 | -$0.51 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.